What does Avoro Ventures invest in?
Avoro Ventures invests most often at Series B (100% of the rounds on record), in sectors such as Proteomics, Drug and Lifescience.

Last cheque observed Sep 2024. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.
QuietNew fund $178M, Jul 2021VC firm
3 rounds on record
Mostly Series B: 100% of its rounds
Every round we can evidence, newest first3 appearances
1 round
1 round
1 round
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
Named by the firm itself, on a filing, its Form ADV or its company registration2 named
The latest companies Avoro Ventures put money into.
Avoro Ventures invests most often at Series B (100% of the rounds on record), in sectors such as Proteomics, Drug and Lifescience.
3 investments on record, 0 of them in the last 12 months. The most recent was in Sept 2024.
Its most recent investments on record: Vicebio (Series B, Sept 2024), Hemab Therapeutics (Series B, Feb 2023) and Vanqua Bio (Series B, Sept 2021).
The median round it joins is $100M.
No investments in the last 12 months; the latest was in Sept 2024.
Avoro Ventures is a VC firm.
Its latest fund filing with the SEC was in Jul 2021, reporting $178M raised.
Avoro Ventures was founded in 1999.
Find the investors who back rounds like yours, and keep every conversation on one fundraising board.
Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it